Biostar Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BSPM research report →
Price Chart
About the company
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B.
- CEO
- Rong Hua Wang
- IPO
- 2008
- Employees
- 200
- HQ
- Xianyang, SN, CN
Get TickerSpark's AI analysis on BSPM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $264
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.27
- Div Yield
- 0.00%
- Gross Margin
- 38.39%
- Op Margin
- -149.50%
- Net Margin
- -239.01%
- ROE
- -14.04%
- ROIC
- -9.09%
Latest fiscal year · YoY change
- Revenue
- $2.38M-91.2%
- Gross Profit
- $915.17K-91.8%
- Op Income
- $-3,564,000
- Net Income
- $-5,698,000+77.3%
- EPS
- $-2.50+78.0%
- OCF Growth
- -16.4%
- FCF Growth
- -15.6%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 8.33
- RSI (14)
- 52
- Avg Volume
- 64
No earnings-call transcripts are available for BSPM yet.
- Free Float
- 83.8%
- Shares Outstanding
- 2.64M
- Float Shares
- 2.21M
of shares held by institutions
1 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 28, 17 | Chen Melissa Fan | other | 0 |
| Dec 31, 09 | Shang Zhongyang | other | 16,667 |
| Oct 22, 09 | Wang Zhenghong | other | 6,667 |
| Apr 20, 12 | Pan Zibing | other | 24,000 |
| Jun 16, 11 | Wang Ronghua | buy | 13,800 |
| Jun 15, 11 | Wang Ronghua | buy | 14,350 |
| Jun 14, 11 | Wang Ronghua | buy | 35,100 |
| Jun 13, 11 | Wang Ronghua | buy | 22,050 |
| Jun 10, 11 | Wang Ronghua | buy | 19,700 |
| Jun 9, 11 | Wang Ronghua | buy | 12,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BSPM coverage
Recent articles, reports, and earnings notes.
No research on BSPM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BSPM report →